Clinic closure leaves indigent dialysis patients looking for treatment

A clinic closure in Atlanta has patients and clinic officials struggling to find new providers that will treat low-income patients who need kidney dialysis, The Associated Press reports.

"The treatment typically costs $40,000 to $50,000 a year, and Grady is just one of the struggling public hospitals cutting the service to reduce costs. Many indigent dialysis patients … are illegal immigrants, so facilities that give them routine treatments receive no federal money for their care." The clinic closed in October, but patients have been getting private dialysis treatments funded by the clinic — Grady Memorial Hospital. Other hospitals in Miami and Las Vegas are facing similar cuts and dilemmas.

"Patients who need dialysis can't survive long without it. Hospitals can get reimbursed by Medicaid, the state-federal program that helps low-income people, when they provide emergency dialysis for illegal immigrants in life-or-death situations. But the reimbursement doesn't come close to covering what hospitals actually spend." Some patients are suing Grady, which has offered to fly the immigrants home for free, but a judge threw the case out in December. Patients are appealing (Brumback, 2/3).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New FDA award fuels research into autosomal dominant tubulointerstitial kidney disease